IRIS
GAETA, Giovanni Battista
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.478
NA - Nord America 7.174
AS - Asia 5.478
SA - Sud America 1.072
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 10
Totale 28.314
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.989
US - Stati Uniti d'America 7.052
SG - Singapore 1.982
IE - Irlanda 1.789
CN - Cina 1.301
HK - Hong Kong 1.020
UA - Ucraina 977
BR - Brasile 910
GB - Regno Unito 795
DE - Germania 539
VN - Vietnam 472
IT - Italia 340
SE - Svezia 292
FI - Finlandia 279
GR - Grecia 175
IN - India 165
TR - Turchia 150
FR - Francia 135
KR - Corea 98
AR - Argentina 67
CA - Canada 66
JP - Giappone 64
BD - Bangladesh 43
BE - Belgio 34
CZ - Repubblica Ceca 30
IQ - Iraq 30
ID - Indonesia 28
MX - Messico 28
AT - Austria 23
EC - Ecuador 22
IR - Iran 22
NL - Olanda 20
PL - Polonia 20
PY - Paraguay 19
PK - Pakistan 18
ZA - Sudafrica 17
EU - Europa 15
EG - Egitto 14
VE - Venezuela 14
MA - Marocco 13
CO - Colombia 11
TW - Taiwan 11
CL - Cile 9
TH - Thailandia 9
AU - Australia 8
DO - Repubblica Dominicana 8
PE - Perù 8
UZ - Uzbekistan 8
DZ - Algeria 7
ET - Etiopia 7
PH - Filippine 7
UY - Uruguay 7
AZ - Azerbaigian 6
CH - Svizzera 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
ES - Italia 5
JO - Giordania 5
RO - Romania 5
TT - Trinidad e Tobago 5
JM - Giamaica 4
NP - Nepal 4
CI - Costa d'Avorio 3
CR - Costa Rica 3
GH - Ghana 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
LB - Libano 3
LT - Lituania 3
MD - Moldavia 3
MY - Malesia 3
NI - Nicaragua 3
OM - Oman 3
SA - Arabia Saudita 3
SN - Senegal 3
AL - Albania 2
AP - ???statistics.table.value.countryCode.AP??? 2
BB - Barbados 2
BF - Burkina Faso 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
HN - Honduras 2
HU - Ungheria 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
GA - Gabon 1
GE - Georgia 1
Totale 28.303
Salva come PNG Salva come JPEG
Città #
Moscow 3.225
Dublin 1.783
Jacksonville 1.402
Hong Kong 1.012
Chandler 893
Singapore 735
Santa Clara 687
San Jose 445
Dallas 308
Princeton 271
Ashburn 240
Medford 236
Beijing 176
Ho Chi Minh City 161
Boardman 157
Roxbury 140
San Mateo 130
Wilmington 123
Ann Arbor 108
Hanoi 105
Hefei 105
Bengaluru 97
Seoul 96
The Dalles 86
Woodbridge 83
Bremen 77
Munich 77
Cambridge 72
New York 69
São Paulo 64
Nanjing 61
Des Moines 54
Düsseldorf 47
Helsinki 47
Los Angeles 45
Mountain View 40
Jinan 36
Brussels 34
Orem 32
Caserta 29
Brno 27
Nanchang 27
Rio de Janeiro 27
Venice 26
Da Nang 25
Haiphong 25
Napoli 25
Zhengzhou 25
Shanghai 23
Belo Horizonte 22
Guangzhou 22
Rome 22
Shenyang 22
Norwalk 21
Naples 20
Atlanta 18
Changsha 18
Nuremberg 18
Tianjin 18
Turku 18
Campinas 17
Chennai 17
Curitiba 17
Kunming 17
Brasília 16
Porto Alegre 16
Hangzhou 14
Milan 13
Tokyo 13
Frankfurt am Main 12
Ningbo 12
Ninh Bình 12
Baghdad 11
Dhaka 11
Recife 11
Redwood City 11
Santo André 11
Guayaquil 10
Haikou 10
Hebei 10
Houston 10
Hải Dương 10
Ottawa 10
Asunción 9
Auburn Hills 9
Istanbul 9
Kraków 9
Padova 9
Shenzhen 9
Biên Hòa 8
Lanzhou 8
Manaus 8
Taizhou 8
Tashkent 8
Vienna 8
Warsaw 8
Amsterdam 7
Clifton 7
Fortaleza 7
Manchester 7
Totale 14.466
Salva come PNG Salva come JPEG
Nome #
1) Analisi delle discontinuità di distribuzione e dei tempi di accumulo di radiocolloide in epatopatici cronici: risultati preliminari 469
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients 342
ANTI TNF ALFA IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE E SPONDILOARTRITI HBV CARRIERS OCCULTI:STUDIO RETROSPETTIVO SULLA SICUREZZA 301
Detection of in vivo hepatitis B virus surface antigen mutations-A comparison of four routine screening assays 249
ANTI-TNFα TREATMENT IS ASSOCIATED WITH INCREASED LIVER STIFFNESS IN HBV OCCULT CARRIER PATIENTS 180
Characteristics of liver cirrhosis in Italy: Evidence for a decreasing role of HCV aetiology. 173
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life 167
Active recruitment strategy in disadvantaged immigrant populations improves the identification of human immunodeficiency but not of hepatitis B or C virus infections 165
3. HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years. 165
AISF position paper on HCV in immunocompromised patients 162
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 157
Ittero in corso di infezione delle vie urinarie. Presentazione di un caso clinico ed aspetti patogenetici 157
Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya, 156
Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance 152
Bacterial pneumonia in patients with liver cirrhosis, with or without HIV co-infection: a possible definition of antibiotic prophylaxis associated pneumonia (APAP) 151
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 151
AISF position paper on liver disease and pregnancy 149
[Elevata prevalenza ma bassa incidenza della infezione da HGV in pazienti con epatite cronica C] 148
Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy. 148
Adefovir dipivoxil-associated thrombocytopenia in a patient with chronic hepatitis B 145
Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas 144
[Prevalence and risk factors for bacteriuria in patients with cirrhosis] 144
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues. 141
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 141
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy 140
Endotoxin protects against chlorpromazine-induced cholestasis in the isolated perfused rat liver 140
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 138
Changing indications for liver transplant: slow decline of hepatitis viruses in Italy 138
Absence of mutations in the YMDD motif/B region of the hepatitis B polymerase in famciclovir therapy failure 136
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 136
[Spontaneous bacterial peritonitis in patients with liver cirrhosis. Differential aspects with portal thrombosis] 135
Virological patterns of HCV patients with failure to interferon-free regimens. 135
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients. 133
Recommendations for the management of acute hepatitis B: position paper of the italian Society for the study of infectious and tropical diseases 133
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 132
[Cutaneous myiasis from Cordylobia anthropophaga in a traveller returning from Senegal: a case study] 132
Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study 131
Clinical and histological aspects of chronic HCV infection and cirrhosis 130
Different changes in mitochondrial apoptotic pathway in lymphocytes and granulocytes in cirrhotic patients with sepsis. 130
AASLD Practice Guidelines on chronic hepatitis B and HBV infection in Italy 129
Influenza vaccination in patients with cirrhosis and in liver transplant recipients 129
Effect of prednisone priming followed by alpha-interferon in treatment of children with chronic hepatitis B: an interim analysis of a controlled trial 128
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 128
Liver's functional alterations produced from erythromycin estolate in the isolated and perfused rat liver 127
Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure 126
Baseline HBV-DNA level is an important predictor of response to interferon in children with chronic hepatitis B 126
[Visceral leishmaniasis: its epidemiology, clinical picture and therapy] 125
A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3 125
Fattori di rischio per l'infezione tifoidea nell'area geografica del golfo di Napoli 124
Combination of Tenofovir Disoproxil Fumarate and Peginterferon alfa-2a Increases Loss of Hepatitis B Surface Antigen in Patients with Chronic Hepatitis B 123
Hepatitis delta infection in Italian patients: towards the end of the story? 123
Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir 123
Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta 122
[Cryptosporidium infection in immunocompetent and immunocompromised host] 122
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 122
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy. 122
Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma. A Cancer of the Liver Italian Program (CLIP 08)retrospective case-control study 121
Liver toxicity during copper chronic intoxication in rats 121
Effect of endotoxin tolerance on drug hepatotoxicity: amelioration of taurolithocholate cholestasis in the perfused rat liver 121
[Visceral leishmaniasis in Italy. Its epidemiology, clinical picture and therapy] 121
Archi-Prevaleat Project. A National Register of Color-Doppler Ultrasonography of the Epi-Aortic Vessels in Patients Living with HIV. 120
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP) 119
Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial 119
The homeostasis model assessment of insulin resistance score is not predictive of sustained virologic response in chronic hepatiti s C patients 119
Fever of unknown origin: a systematic review of the literature for 1995-2004 119
Influence of tauroursodeoxycholic and taurodeoxycholic acids on hepatic metabolism and biliary secretion of phosphatidylcholine in the isolated rat liver 119
Effects of bacterial lipopolysaccharide (LPS) on chlorpromazine (CPZ) induced cholestasis in the isolated perfused rat liver 119
Amphotericin B-induced depression in the phagocytic function of the isolated rat liver and its prevention by nifedipine 118
Effect of pretreatment with bacterial endotoxin on erythromycin estolate-induced cholestasis 118
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER cohort study (PLoS ONE (2017) 12: 2 (e0172159) DOI: 10.1371/journal.pone.0172159) 118
Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin 117
Functional changes induced by taurolithocolic acid in the isolated perfused rat liver 117
Efficacy of amphotericin B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent adult patients 116
Bacterial endotoxin treatment ameliorates erythromycin estolate-induced cholestasis in the isolated perfused rat liver 116
Doctors in the kitchen. Experiments with cooking bivalve mollusks 115
Chronic endotoxin pretreatment protects from the chlorpromazine induced cholestasis 115
Pretreatment of isolated rat hepatocytes with endotoxin decreases erythromicin estolate - induced aspartate transaminase release 115
Bacterial endotoxin effect on liver plasma membranes (LPM): membrane-bound enzymes as probes of the site of interaction 115
Discriminating value of serum bile acids in asymptomatic HBsAg carriers 115
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required? 115
Effetto della eritromicina sulle funzioni escretorie del fegato di ratto isolato 114
Severe polymyositis due to Toxoplasma gondii in an adult immunocompetent patient: a case report and review of the literature. 114
Cholestasis induced by estradiol-17 beta-D-glucuronide: mechanisms and prevention by sodium taurocholate 113
Cholestatic effect of amphotericin B on the isolated perfused rat liver. Preliminary study 112
Hepatic excretory function in the endotoxin tolerant rat 112
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort 112
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis 111
Endotoxin reduces erythromycine estolate-induced releas of aspartate transaminase from isolated rat liver cells 111
Increased liver stiffness in idiopathic pulmonary fibrosis: a pilot study 111
Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy 110
The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis 110
Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study 109
Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts 108
Interference of endotoxin pretreatment on the taurolithocholate induced cholestasis 108
The role of surgery in transmitting "post-transfusion" hepatitis 107
The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients 107
Potentation of ethanol-induced narcosis in mice by pretreatment with bacterial lipopolysaccharide 107
Prospective Validation of the CLIP Score: A New Prognostic System for Patients With Cirrhosis and Hepatocellular Carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators 107
Hepatitis C virus infection in Italy: a multicentric sero-epidemiological study. (A report from the HCV study group of the Italian Association for the study of the liver) 106
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates) 106
Totale 13.623
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.625
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.625
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021546 0 0 0 0 0 0 0 0 0 264 222 60
2021/20221.690 148 11 17 62 590 14 30 65 70 97 132 454
2022/20233.346 293 45 38 302 311 286 6 216 1.694 26 56 73
2023/20241.143 113 34 51 110 438 75 10 35 4 25 57 191
2024/20253.550 58 53 34 102 502 309 582 308 526 622 263 191
2025/202613.899 407 516 929 762 1.133 8.376 689 351 552 184 0 0
Totale 28.603